\-\ Texto\\:\\ \ \(0\)\
\-\ not\\ available\ \(73\)\
\-\ this\\ patient\\ was\\ assessed\\ as\\ a\\ possible\\ surgical\\ candidate\\,\\ but\\ at\\ the\\ time\\ of\\ this\\ write\\-up\\ had\\ not\\ elected\\ for\\ surgery\\.\\ initial\\ treatment\\ of\\ osteoarthritis\\ is\\ conservative\\,\\ with\\ a\\ goal\\ of\\ pain\\ reduction\\ and\\ minimization\\ of\\ swelling\\ and\\ disability\\.\\ at\\ present\\ there\\ are\\ no\\ pharmacologic\\ therapies\\ that\\ prevent\\ the\\ progression\\ of\\ damage\\ due\\ to\\ osteoarthritis\\.\\ conservative\\ nonpharmacologic\\ therapies\\ include\\ tailored\\ exercise\\ programs\\,\\ weight\\ loss\\ \\(when\\ appropriate\\)\\,\\ and\\ specially\\ designed\\ shoes\\.\\ dietary\\ supplements\\ such\\ as\\ glucosamine\\ and\\ chondroitin\\ may\\ also\\ be\\ useful\\.\\ pharmacologic\\ intervention\\ includes\\ non\\-opioid\\ analgesics\\ and\\ anti\\-inflammatory\\ drugs\\ for\\ long\\-term\\ pain\\ control\\,\\ and\\ in\\ severe\\ cases\\ opiates\\ for\\ acute\\ exacerbations\\.\\ surgical\\ intervention\\ is\\ considered\\ as\\ a\\ final\\ option\\ in\\ patients\\ with\\ severe\\ symptomatic\\ oa\\ of\\ the\\ hip\\ in\\ which\\ medical\\ management\\ is\\ insufficient\\,\\ and\\ there\\ is\\ marked\\ interference\\ with\\ daily\\ activities\\.\\ \\ total\\ hip\\ arthroplasty\\ \\(replacement\\)\\,\\ may\\ provide\\ marked\\ pain\\ relief\\ as\\ well\\ as\\ significant\\ functional\\ improvement\\.\ \(0\)\
\-\ ap\\ and\\ frog\\-leg\\ views\\ of\\ the\\ hips\\ demonstrating\\ marked\\ joint\\ space\\ narrowing\\ bilaterally\\,\\ especially\\ in\\ the\\ superolateral\\ regions\\.\\ \\ there\\ is\\ also\\ evidence\\ of\\ subchondral\\ sclerosis\\ and\\ cyst\\ formation\\.\\ in\\ the\\ superior\\ aspects\\ of\\ the\\ acetabula\\,\\ large\\ osteophytes\\ are\\ present\\ bilaterally\\.\\ \ \(0\)\
\-\ both\\ femoral\\ heads\\ demonstrate\\ contour\\ abnormalities\\ consistent\\ with\\ slipped\\ capital\\ femoral\\ epiphyses\\,\\ the\\ right\\ side\\ greater\\ than\\ the\\ left\\.\\ \ \(0\)\
\-\ there\\ is\\ no\\ evidence\\ of\\ flattening\\ or\\ collapse\\ of\\ the\\ femoral\\ heads\\,\\ and\\ they\\ are\\ well\\ covered\\ by\\ the\\ acetabulum\\.\ \(0\)\
\-\ osteoarthritis\\ of\\ the\\ hips\\ bilaterally\\,\\ secondary\\ to\\ slipped\\ capital\\ femoral\\ epiphyses\\.\ \(0\)\
\-\ osteoarthritis\ \(102\)\
\-\ the\\ patient\\ is\\ a\\ 52\\ year\\-old\\ african\\-american\\ male\\ with\\ bilateral\\ djd\\ secondary\\ to\\ slipped\\ capital\\ femoral\\ epiphyses\\ at\\ a\\ young\\ age\\.\ \(0\)\
\-\ slipped\\ capital\\ femoral\\ epiphysis\\ \\(scfe\\)\\ is\\ the\\ displacement\\ of\\ the\\ epiphysis\\ from\\ the\\ femoral\\ neck\\ at\\ the\\ physeal\\ plate\\.\\ the\\ typical\\ patient\\ is\\ an\\ obese\\ male\\ in\\ early\\ adolescence\\,\\ although\\ it\\ is\\ not\\ uncommon\\ in\\ obese\\ females\\.\\ at\\ presentation\\ nearly\\ 20\\%\\ of\\ cases\\ are\\ bilateral\\ \\(1\\)\\,\\ and\\ of\\ those\\ with\\ a\\ unilateral\\ slip\\ 30\\-60\\%\\ will\\ eventually\\ have\\ a\\ slip\\ in\\ the\\ contralateral\\ hip\\.\\ risk\\ factors\\ include\\ obesity\\,\\ renal\\ failure\\,\\ history\\ of\\ radiation\\ therapy\\,\\ some\\ endocrine\\ abnormalities\\ \\(gh\\ deficiency\\ and\\ hypothyroidism\\)\\,\\ and\\ certain\\ genetic\\ disorders\\ \\(eg\\,\\ down\\ syndrome\\)\\.\\ \\ scfe\\ is\\ caused\\ by\\ shearing\\ forces\\ applied\\ to\\ the\\ femoral\\ head\\ which\\ exceed\\ the\\ strength\\ of\\ the\\ capital\\ physis\\.\\ pain\\ and\\ altered\\ gait\\ are\\ the\\ common\\ presenting\\ complaints\\ of\\ scfe\\.\\ diagnosis\\ can\\ often\\ be\\ made\\ by\\ plain\\ films\\ alone\\.\\ mri\\ may\\ be\\ used\\ for\\ diagnosis\\ when\\ clinical\\ suspicion\\ is\\ high\\ but\\ there\\ is\\ no\\ radiographic\\ evidence\\.\\ in\\ fact\\,\\ mri\\ is\\ quickly\\ becoming\\ the\\ modality\\ of\\ choice\\ in\\ these\\ equivocal\\ cases\\ \\(2\\)\\.\\ patients\\ with\\ a\\ history\\ of\\ scfe\\ have\\ a\\ significantly\\ increased\\ risk\\ of\\ developing\\ osteoarthritis\\ especially\\ if\\ left\\ untreated\\ \\(3\\)\\.\\ the\\ rate\\ of\\ development\\ of\\ osteoarthritis\\ is\\ related\\ to\\ the\\ severity\\ of\\ the\\ slip\\.\\ common\\ radiographic\\ findings\\ of\\ osteoarthritis\\ include\\ asymmetric\\ joint\\ space\\ narrowing\\,\\ osteophytes\\,\\ periartcular\\ sclerosis\\,\\ and\\ subarticular\\ cysts\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ osteoarthritis\\:\\ 0\\.2683542860192416\ \(0\)\
\-\ femoral\\:\\ 0\\.24955042012693562\ \(0\)\
\-\ capital\\:\\ 0\\.24123723079776946\ \(0\)\
\-\ the\\:\\ 0\\.22611227099145964\ \(0\)\
\-\ of\\:\\ 0\\.20533340392397947\ \(0\)\
\-\ scfe\\:\\ 0\\.20071118458985684\ \(0\)\
\-\ slipped\\:\\ 0\\.18781330915180278\ \(0\)\
\-\ slip\\:\\ 0\\.17370564625098353\ \(0\)\
\-\ is\\:\\ 0\\.17240639615602948\ \(0\)\
\-\ epiphyses\\:\\ 0\\.15545873701212923\ \(0\)\
\-\ and\\:\\ 0\\.13008868788902356\ \(0\)\
\-\ pharmacologic\\:\\ 0\\.11383884472479412\ \(0\)\
\-\ in\\:\\ 0\\.10440764907120453\ \(0\)\
\-\ therapies\\:\\ 0\\.0982989900795178\ \(0\)\
\-\ hip\\:\\ 0\\.09672072319184827\ \(0\)\
\-\ marked\\:\\ 0\\.0952300264697295\ \(0\)\
\-\ heads\\:\\ 0\\.09052845807072993\ \(0\)\
\-\ osteophytes\\:\\ 0\\.08943795648552856\ \(0\)\
\-\ hips\\:\\ 0\\.08842272379817272\ \(0\)\
\-\ obese\\:\\ 0\\.08687233986506272\ \(0\)\
\-\ cases\\:\\ 0\\.08468756544918442\ \(0\)\
\-\ as\\:\\ 0\\.08430412003641323\ \(0\)\
\-\ bilaterally\\:\\ 0\\.0839728249691547\ \(0\)\
\-\ there\\:\\ 0\\.08349859181089747\ \(0\)\
\-\ epiphysis\\:\\ 0\\.08301163988924208\ \(0\)\
\-\ are\\:\\ 0\\.07962846248667134\ \(0\)\
\-\ at\\:\\ 0\\.07926293335405006\ \(0\)\
\-\ include\\:\\ 0\\.07491523912152498\ \(0\)\
\-\ evidence\\:\\ 0\\.07146664303387067\ \(0\)\
\-\ intervention\\:\\ 0\\.07051131489238527\ \(0\)\
\-\ minimization\\:\\ 0\\.06711910907910502\ \(0\)\
\-\ nonpharmacologic\\:\\ 0\\.06711910907910502\ \(0\)\
\-\ specially\\:\\ 0\\.06711910907910502\ \(0\)\
\-\ glucosamine\\:\\ 0\\.06711910907910502\ \(0\)\
\-\ chondroitin\\:\\ 0\\.06711910907910502\ \(0\)\
\-\ periartcular\\:\\ 0\\.06711910907910502\ \(0\)\
\-\ especially\\:\\ 0\\.06639957457155427\ \(0\)\
\-\ narrowing\\:\\ 0\\.06507047356695403\ \(0\)\
\-\ conservative\\:\\ 0\\.0648053305837825\ \(0\)\
\-\ may\\:\\ 0\\.06336182762405375\ \(0\)\
\-\ radiographic\\:\\ 0\\.06227654761820552\ \(0\)\
\-\ opiates\\:\\ 0\\.06201926572075104\ \(0\)\
\-\ interference\\:\\ 0\\.06201926572075104\ \(0\)\
\-\ abnormalities\\:\\ 0\\.060803815777932875\ \(0\)\
\-\ pain\\:\\ 0\\.06007359045701155\ \(0\)\
\-\ risk\\:\\ 0\\.059976637246713316\ \(0\)\
\-\ sclerosis\\:\\ 0\\.05978858309057703\ \(0\)\
\-\ tailored\\:\\ 0\\.05903604859656212\ \(0\)\
\-\ programs\\:\\ 0\\.05903604859656212\ \(0\)\
\-\ designed\\:\\ 0\\.05903604859656212\ \(0\)\
\-\ insufficient\\:\\ 0\\.05903604859656212\ \(0\)\
\-\ adolescence\\:\\ 0\\.05790188208366118\ \(0\)\
\-\ gh\\:\\ 0\\.05790188208366118\ \(0\)\
\-\ with\\:\\ 0\\.057527705363490826\ \(0\)\
\-\ supplements\\:\\ 0\\.05691942236239706\ \(0\)\
\-\ shearing\\:\\ 0\\.05691942236239706\ \(0\)\
\-\ shoes\\:\\ 0\\.056052831472373194\ \(0\)\
\-\ acetabula\\:\\ 0\\.056052831472373194\ \(0\)\
\-\ exceed\\:\\ 0\\.056052831472373194\ \(0\)\
\-\ space\\:\\ 0\\.055874080358492735\ \(0\)\
\-\ joint\\:\\ 0\\.055312101325098194\ \(0\)\
\-\ subarticular\\:\\ 0\\.055277639505818196\ \(0\)\
\-\ exacerbations\\:\\ 0\\.05457639307347182\ \(0\)\
\-\ djd\\:\\ 0\\.05457639307347182\ \(0\)\
\-\ by\\:\\ 0\\.05346864239414211\ \(0\)\
\-\ severe\\:\\ 0\\.05313760507019833\ \(0\)\
\-\ to\\:\\ 0\\.05246204260062994\ \(0\)\
\-\ superolateral\\:\\ 0\\.05229442238162927\ \(0\)\
\-\ elected\\:\\ 0\\.051819579004043076\ \(0\)\
\-\ be\\:\\ 0\\.051076609394766714\ \(0\)\
\-\ becoming\\:\\ 0\\.05095298811401921\ \(0\)\
\-\ for\\:\\ 0\\.05088309574396913\ \(0\)\
\-\ when\\:\\ 0\\.05070457339283285\ \(0\)\
\-\ assessed\\:\\ 0\\.05055518752125459\ \(0\)\
\-\ equivocal\\:\\ 0\\.05017779614746421\ \(0\)\
\-\ arthroplasty\\:\\ 0\\.049818821601118266\ \(0\)\
\-\ secondary\\:\\ 0\\.04975331191055266\ \(0\)\
\-\ not\\:\\ 0\\.04970623009816837\ \(0\)\
\-\ oa\\:\\ 0\\.049476549715117835\ \(0\)\
\-\ applied\\:\\ 0\\.049476549715117835\ \(0\)\
\-\ quickly\\:\\ 0\\.049476549715117835\ \(0\)\
\-\ dietary\\:\\ 0\\.0491494950397589\ \(0\)\
\-\ covered\\:\\ 0\\.0491494950397589\ \(0\)\
\-\ physeal\\:\\ 0\\.048536013290885346\ \(0\)\
\-\ forces\\:\\ 0\\.048536013290885346\ \(0\)\
\-\ untreated\\:\\ 0\\.048536013290885346\ \(0\)\
\-\ analgesics\\:\\ 0\\.04824744615955389\ \(0\)\
\-\ goal\\:\\ 0\\.04770219536695321\ \(0\)\
\-\ common\\:\\ 0\\.04760355355895085\ \(0\)\
\-\ certain\\:\\ 0\\.04744401032444778\ \(0\)\
\-\ patients\\:\\ 0\\.047220800000213205\ \(0\)\
\-\ obesity\\:\\ 0\\.04649333259092891\ \(0\)\
\-\ disability\\:\\ 0\\.046273688855635785\ \(0\)\
\-\ activities\\:\\ 0\\.04606041251037434\ \(0\)\
\-\ acetabulum\\:\\ 0\\.04606041251037434\ \(0\)\
\-\ candidate\\:\\ 0\\.04585314475566523\ \(0\)\
\-\ endocrine\\:\\ 0\\.045651556290101404\ \(0\)\
\-\ bilateral\\:\\ 0\\.045112414608390224\ \(0\)\
\-\ physis\\:\\ 0\\.045077952789110226\ \(0\)\
\-\ eg\\:\\ 0\\.04471897824276428\ \(0\)\
\-\ hypothyroidism\\:\\ 0\\.043736518521500165\ \(0\)\
\-\ diagnosis\\:\\ 0\\.04351386357025994\ \(0\)\
\-\ aspects\\:\\ 0\\.04343616993253136\ \(0\)\
\-\ mri\\:\\ 0\\.04308731087973706\ \(0\)\
\-\ present\\:\\ 0\\.043072303191088075\ \(0\)\
\-\ altered\\:\\ 0\\.04260235200859922\ \(0\)\
\-\ provide\\:\\ 0\\.04247212703871168\ \(0\)\
\-\ option\\:\\ 0\\.0423441669660938\ \(0\)\
\-\ females\\:\\ 0\\.0422183943526038\ \(0\)\
\-\ drugs\\:\\ 0\\.04197312101634694\ \(0\)\
\-\ contralateral\\:\\ 0\\.04197312101634694\ \(0\)\
\-\ have\\:\\ 0\\.041932598120160286\ \(0\)\
\-\ nearly\\:\\ 0\\.04185348392959671\ \(0\)\
\-\ eventually\\:\\ 0\\.04185348392959671\ \(0\)\
\-\ but\\:\\ 0\\.041508425412516384\ \(0\)\
\-\ modality\\:\\ 0\\.04150581994462104\ \(0\)\
\-\ flattening\\:\\ 0\\.04139348923257492\ \(0\)\
\-\ genetic\\:\\ 0\\.04139348923257492\ \(0\)\
\-\ severity\\:\\ 0\\.04139348923257492\ \(0\)\
\-\ alone\\:\\ 0\\.041282847768320044\ \(0\)\
\-\ final\\:\\ 0\\.0411738454972818\ \(0\)\
\-\ functional\\:\\ 0\\.0411738454972818\ \(0\)\
\-\ deficiency\\:\\ 0\\.04106643455721599\ \(0\)\
\-\ patient\\:\\ 0\\.04095216689871342\ \(0\)\
\-\ no\\:\\ 0\\.04094446403485328\ \(0\)\
\-\ damage\\:\\ 0\\.040856205434496515\ \(0\)\
\-\ surgical\\:\\ 0\\.040797542981325166\ \(0\)\
\-\ well\\:\\ 0\\.040644126779046066\ \(0\)\
\-\ fact\\:\\ 0\\.04025932271967398\ \(0\)\
\-\ subchondral\\:\\ 0\\.040164385677010986\ \(0\)\
\-\ developing\\:\\ 0\\.040164385677010986\ \(0\)\
\-\ useful\\:\\ 0\\.04007065805634831\ \(0\)\
\-\ suspicion\\:\\ 0\\.03988671050728737\ \(0\)\
\-\ daily\\:\\ 0\\.03979643307131742\ \(0\)\
\-\ choice\\:\\ 0\\.03979643307131742\ \(0\)\
\-\ exercise\\:\\ 0\\.03953206264070293\ \(0\)\
\-\ also\\:\\ 0\\.039482936327184755\ \(0\)\
\-\ significantly\\:\\ 0\\.039446008809167224\ \(0\)\
\-\ relief\\:\\ 0\\.03936094984190488\ \(0\)\
\-\ collapse\\:\\ 0\\.03936094984190488\ \(0\)\
\-\ 52\\:\\ 0\\.03887026680540778\ \(0\)\
\-\ prevent\\:\\ 0\\.03848496837150935\ \(0\)\
\-\ progression\\:\\ 0\\.03848496837150935\ \(0\)\
\-\ plate\\:\\ 0\\.03848496837150935\ \(0\)\
\-\ unilateral\\:\\ 0\\.038410272108386\ \(0\)\
\-\ which\\:\\ 0\\.038168320285487584\ \(0\)\
\-\ uncommon\\:\\ 0\\.03797735202783143\ \(0\)\
\-\ contour\\:\\ 0\\.03777008427312232\ \(0\)\
\-\ asymmetric\\:\\ 0\\.03777008427312232\ \(0\)\
\-\ replacement\\:\\ 0\\.03770227256062986\ \(0\)\
\-\ male\\:\\ 0\\.03737328483446736\ \(0\)\
\-\ disorders\\:\\ 0\\.037056461860191924\ \(0\)\
\-\ appropriate\\:\\ 0\\.036873277657992955\ \(0\)\
\-\ reduction\\:\\ 0\\.03663591776022137\ \(0\)\
\-\ improvement\\:\\ 0\\.03663591776022137\ \(0\)\
\-\ gait\\:\\ 0\\.0363495968565741\ \(0\)\
\-\ regions\\:\\ 0\\.036020100661789275\ \(0\)\
\-\ those\\:\\ 0\\.035913468089216645\ \(0\)\
\-\ control\\:\\ 0\\.03586072579366637\ \(0\)\
\-\ factors\\:\\ 0\\.035501751247320426\ \(0\)\
\-\ strength\\:\\ 0\\.035159479361319995\ \(0\)\
\-\ development\\:\\ 0\\.03469658971296344\ \(0\)\
\-\ demonstrating\\:\\ 0\\.03460740657590566\ \(0\)\
\-\ young\\:\\ 0\\.03460740657590566\ \(0\)\
\-\ complaints\\:\\ 0\\.03456321714143541\ \(0\)\
\-\ total\\:\\ 0\\.03438906655616877\ \(0\)\
\-\ displacement\\:\\ 0\\.03421894293708751\ \(0\)\
\-\ down\\:\\ 0\\.03409388295072018\ \(0\)\
\-\ caused\\:\\ 0\\.03365270063603244\ \(0\)\
\-\ formation\\:\\ 0\\.033273363086136966\ \(0\)\
\-\ films\\:\\ 0\\.03323648321582339\ \(0\)\
\-\ views\\:\\ 0\\.03312693997064995\ \(0\)\
\-\ presenting\\:\\ 0\\.03287750866947745\ \(0\)\
\-\ considered\\:\\ 0\\.032704382594234374\ \(0\)\
\-\ includes\\:\\ 0\\.032636256934152855\ \(0\)\
\-\ typical\\:\\ 0\\.032435584893666186\ \(0\)\
\-\ made\\:\\ 0\\.032369892325799524\ \(0\)\
\-\ symptomatic\\:\\ 0\\.03227244032200371\ \(0\)\
\-\ history\\:\\ 0\\.032069911722483226\ \(0\)\
\-\ related\\:\\ 0\\.031895048948213336\ \(0\)\
\-\ failure\\:\\ 0\\.03186445631069657\ \(0\)\
\-\ rate\\:\\ 0\\.031803650024744466\ \(0\)\
\-\ cysts\\:\\ 0\\.031803650024744466\ \(0\)\
\-\ used\\:\\ 0\\.03142020557062714\ \(0\)\
\-\ management\\:\\ 0\\.031001258327683447\ \(0\)\
\-\ greater\\:\\ 0\\.03092025730343529\ \(0\)\
\-\ early\\:\\ 0\\.03025326609163446\ \(0\)\
\-\ ap\\:\\ 0\\.0301316514430601\ \(0\)\
\-\ they\\:\\ 0\\.029988318623356658\ \(0\)\
\-\ weight\\:\\ 0\\.029267741376065495\ \(0\)\
\-\ side\\:\\ 0\\.0289940395923662\ \(0\)\
\-\ presentation\\:\\ 0\\.028891422605050166\ \(0\)\
\-\ this\\:\\ 0\\.02884327078996699\ \(0\)\
\-\ left\\:\\ 0\\.028633740066579736\ \(0\)\
\-\ although\\:\\ 0\\.02857234740489665\ \(0\)\
\-\ available\\:\\ 0\\.0284754089970469\ \(0\)\
\-\ possible\\:\\ 0\\.028436988446438213\ \(0\)\
\-\ swelling\\:\\ 0\\.028247838730620527\ \(0\)\
\-\ initial\\:\\ 0\\.02815505668491384\ \(0\)\
\-\ radiation\\:\\ 0\\.02781278479891341\ \(0\)\
\-\ plain\\:\\ 0\\.027690593067416096\ \(0\)\
\-\ often\\:\\ 0\\.027385398768053675\ \(0\)\
\-\ superior\\:\\ 0\\.02728641720272237\ \(0\)\
\-\ 20\\:\\ 0\\.027076418878777087\ \(0\)\
\-\ will\\:\\ 0\\.027012991600430473\ \(0\)\
\-\ such\\:\\ 0\\.02699721985007721\ \(0\)\
\-\ medical\\:\\ 0\\.026673590941284984\ \(0\)\
\-\ clinical\\:\\ 0\\.026598590100978536\ \(0\)\
\-\ some\\:\\ 0\\.02640709231741772\ \(0\)\
\-\ age\\:\\ 0\\.026349158799806035\ \(0\)\
\-\ renal\\:\\ 0\\.026135882454544596\ \(0\)\
\-\ neck\\:\\ 0\\.025674189247970068\ \(0\)\
\-\ loss\\:\\ 0\\.02556964015348953\ \(0\)\
\-\ syndrome\\:\\ 0\\.025302064530612456\ \(0\)\
\-\ head\\:\\ 0\\.025031808084706116\ \(0\)\
\-\ time\\:\\ 0\\.02487665595527633\ \(0\)\
\-\ if\\:\\ 0\\.0243855919666616\ \(0\)\
\-\ significant\\:\\ 0\\.024232532565640976\ \(0\)\
\-\ cyst\\:\\ 0\\.024210924565609516\ \(0\)\
\-\ due\\:\\ 0\\.02412512162557517\ \(0\)\
\-\ therapy\\:\\ 0\\.024114466274368286\ \(0\)\
\-\ high\\:\\ 0\\.023852977533925165\ \(0\)\
\-\ than\\:\\ 0\\.02379157924669618\ \(0\)\
\-\ these\\:\\ 0\\.02370043194405196\ \(0\)\
\-\ both\\:\\ 0\\.023404513290680266\ \(0\)\
\-\ consistent\\:\\ 0\\.02275707785799348\ \(0\)\
\-\ acute\\:\\ 0\\.022704145840321963\ \(0\)\
\-\ increased\\:\\ 0\\.022695360742296236\ \(0\)\
\-\ surgery\\:\\ 0\\.02256482771376053\ \(0\)\
\-\ can\\:\\ 0\\.02202450740800705\ \(0\)\
\-\ demonstrate\\:\\ 0\\.02181902091918786\ \(0\)\
\-\ it\\:\\ 0\\.021483837884995482\ \(0\)\
\-\ large\\:\\ 0\\.021029035270128733\ \(0\)\
\-\ had\\:\\ 0\\.020910979109823292\ \(0\)\
\-\ findings\\:\\ 0\\.02071386058286744\ \(0\)\
\-\ treatment\\:\\ 0\\.019992520777843806\ \(0\)\
\-\ that\\:\\ 0\\.01821339037061993\ \(0\)\
\-\ from\\:\\ 0\\.016668690298387495\ \(0\)\
\-\ an\\:\\ 0\\.01604917329314857\ \(0\)\
\-\ was\\:\\ 0\\.014626947922808286\ \(0\)\
\-\ or\\:\\ 0\\.014600603089209425\ \(0\)\
\-\ right\\:\\ 0\\.013914779557660314\ \(0\)\
